Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Devilee

Showing results (31-40 of 282) with videos related to

Pageof 29
Sort By:
Breast (Edinburgh, Scotland)|August 29, 2021
Information needs on breast cancer genetic and non-genetic risk factors in relatives of women with a BRCA1/2 or PALB2 pathogenic variantAnne Brédart, Antoine De Pauw, Amélie Anota, et al.
International Journal of Cancer|January 22, 2002
Association between BRCA1 and BRCA2 mutations and cancer phenotype in Spanish breast/ovarian cancer families: implications for genetic testingMiguel de la Hoya, Ana Osorio, Javier Godino, et al.
BMC Medical Genomics|May 13, 2009
Similar gene expression profiles of sporadic, PGL2-, and SDHD-linked paragangliomas suggest a common pathway to tumorigenesisErik F Hensen, Jelle J Goeman, Jan Oosting, et al.
European Journal of Cancer (Oxford, England : 1990)|December 25, 2004
Prevalence and clinical correlations of BRCA1/BRCA2 unclassified variant carriers among unselected primary ovarian cancer cases - preliminary reportEwa J Majdak, Geertruida H De Bock, Izabela Brozek, et al.
International Journal of Cancer|May 24, 2007
Increased HIF1 alpha in SDH and FH deficient tumors does not cause microsatellite instabilityHeli J Lehtonen, Markus J Mäkinen, Maija Kiuru, et al.
Human Mutation|August 12, 2008
Intronic variants in BRCA1 and BRCA2 that affect RNA splicing can be reliably selected by splice-site prediction programsMaaike P G Vreeswijk, Jaennelle N Kraan, Heleen M van der Klift, et al.
International Journal of Cancer|May 9, 2020
Clustering of known low and moderate risk alleles rather than a novel recessive high-risk gene in non-BRCA1/2 sib trios affected with breast cancerFlorentine S Hilbers, Peter J van 't Hof, Caro M Meijers, et al.
The EMBO Journal|March 30, 2023
LncRNA LITATS1 suppresses TGF-β-induced EMT and cancer cell plasticity by potentiating TβRI degradationChuannan Fan, Qian Wang, Thomas B Kuipers, et al.
Plos One|December 4, 2009
Sdhd and SDHD/H19 knockout mice do not develop paraganglioma or pheochromocytomaJean-Pierre Bayley, Ivonne van Minderhout, Pancras C W Hogendoorn, et al.
International Journal of Cancer|September 24, 2004
Mutant BRCA1 alleles transmission: different approaches and different biasesMiguel de la Hoya, Hanne Meijers-Heijboer, Juan Manuel Fernández, et al.
Pageof 29

Showing results (31-40 of 282) with videos related to

Sort By:
Pageof 29
Breast (Edinburgh, Scotland)|August 29, 2021
Information needs on breast cancer genetic and non-genetic risk factors in relatives of women with a BRCA1/2 or PALB2 pathogenic variantAnne Brédart, Antoine De Pauw, Amélie Anota, et al.
International Journal of Cancer|January 22, 2002
Association between BRCA1 and BRCA2 mutations and cancer phenotype in Spanish breast/ovarian cancer families: implications for genetic testingMiguel de la Hoya, Ana Osorio, Javier Godino, et al.
BMC Medical Genomics|May 13, 2009
Similar gene expression profiles of sporadic, PGL2-, and SDHD-linked paragangliomas suggest a common pathway to tumorigenesisErik F Hensen, Jelle J Goeman, Jan Oosting, et al.
European Journal of Cancer (Oxford, England : 1990)|December 25, 2004
Prevalence and clinical correlations of BRCA1/BRCA2 unclassified variant carriers among unselected primary ovarian cancer cases - preliminary reportEwa J Majdak, Geertruida H De Bock, Izabela Brozek, et al.
International Journal of Cancer|May 24, 2007
Increased HIF1 alpha in SDH and FH deficient tumors does not cause microsatellite instabilityHeli J Lehtonen, Markus J Mäkinen, Maija Kiuru, et al.
Human Mutation|August 12, 2008
Intronic variants in BRCA1 and BRCA2 that affect RNA splicing can be reliably selected by splice-site prediction programsMaaike P G Vreeswijk, Jaennelle N Kraan, Heleen M van der Klift, et al.
International Journal of Cancer|May 9, 2020
Clustering of known low and moderate risk alleles rather than a novel recessive high-risk gene in non-BRCA1/2 sib trios affected with breast cancerFlorentine S Hilbers, Peter J van 't Hof, Caro M Meijers, et al.
The EMBO Journal|March 30, 2023
LncRNA LITATS1 suppresses TGF-β-induced EMT and cancer cell plasticity by potentiating TβRI degradationChuannan Fan, Qian Wang, Thomas B Kuipers, et al.
Plos One|December 4, 2009
Sdhd and SDHD/H19 knockout mice do not develop paraganglioma or pheochromocytomaJean-Pierre Bayley, Ivonne van Minderhout, Pancras C W Hogendoorn, et al.
International Journal of Cancer|September 24, 2004
Mutant BRCA1 alleles transmission: different approaches and different biasesMiguel de la Hoya, Hanne Meijers-Heijboer, Juan Manuel Fernández, et al.
Pageof 29